title: An African patient with ziprasidone intolerance.
authors.forename: Jakob
authors.initials: J
authors.lastname: Hein
authors.forename: Andreas
authors.initials: A
authors.lastname: Gregor
authors.forename: Andrea
authors.initials: A
authors.lastname: Bartholomä
authors.forename: Andreas
authors.initials: A
authors.lastname: Heinz
authors.forename: Georg
authors.initials: G
authors.lastname: Juckel
mesh_terms: D000349:Africa / Q000208:ethnology; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D000068180:Aripiprazole; D004421:Dystonia / Q000139:chemically induced* / Q000208:ethnology / Q000517:prevention & control; D005006:Ethnicity / Q000235:genetics*; D005858:Germany; D006801:Humans; D008297:Male; D008875:Middle Aged; D010597:Pharmacogenetics; D010879:Piperazines / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D015363:Quinolones / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D013844:Thiazoles / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D013844:Thiazoles; C092292:ziprasidone; D000068180:Aripiprazole